Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase kinase kinase 7 |
---|
Ligand | BDBM50042034 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1633896 (CHEMBL3876688) |
---|
IC50 | 5.6±n/a nM |
---|
Citation | Tan, L; Gurbani, D; Weisberg, EL; Hunter, JC; Li, L; Jones, DS; Ficarro, SB; Mowafy, S; Tam, CP; Rao, S; Du, G; Griffin, JD; Sorger, PK; Marto, JA; Westover, KD; Gray, NS Structure-guided development of covalent TAK1 inhibitors. Bioorg Med Chem25:838-846 (2017) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase kinase kinase 7 |
---|
Name: | Mitogen-activated protein kinase kinase kinase 7 |
Synonyms: | M3K7_HUMAN | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | TAK1 | TAK1/TAB1 | TGF-beta-activated kinase 1 | Transforming growth factor-beta-activated kinase 1 (TAK1) |
Type: | Protein |
Mol. Mass.: | 67199.89 |
Organism: | Homo sapiens (Human) |
Description: | O43318 |
Residue: | 606 |
Sequence: | MSTASAASSSSSSSAGEMIEAPSQVLNFEEIDYKEIEVEEVVGRGAFGVVCKAKWRAKDV
AIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAE
PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC
DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM
WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY
PCQYSDEGQSNSATSTGSFMDIASTNTSNKSDTNMEQVPATNDTIKRLESKLLKNQAKQQ
SESGRLSLGASRGSSVESLPPTSEGKRMSADMSEIEARIAATTAYSKPKRGHRKTASFGN
ILDVPEIVISGNGQPRRRSIQDLTVTGTEPGQVSSRSSSPSVRMITTSGPTSEKPTRSHP
WTPDDSTDTNGSDNSIPMAYLTLDHQLQPLAPCPNSKESMAVFEQHCKMAQEYMKVQTEI
ALLLQRKQELVAELDQDEKDQQNTSRLVQEHKKLLDENKSLSTYYQQCKKQLEVIRSQQQ
KRQGTS
|
|
|
BDBM50042034 |
---|
n/a |
---|
Name | BDBM50042034 |
Synonyms: | (5Z)-7-Oxozeaenol | 5Z-7-Oxozeaenol | CHEBI:67559 | CHEMBL1077979 |
Type | Small organic molecule |
Emp. Form. | C19H22O7 |
Mol. Mass. | 362.3738 |
SMILES | COc1cc(O)c2c(c1)\C=C\C[C@H](O)[C@H](O)C(=O)\C=C/C[C@H](C)OC2=O |r,c:19,t:10| |
Structure |
|